Journal Home
Search for

Volume 60, Issue 3, Pages 200-208 (March 2010)


View previous. 2 of 12 View next.

Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996–2006

Caroline L. TrotteraCorresponding Author Informationemail address, Pauline Waightb, Nick J. Andrewsc, Mary Slackd, Androulla Efstratioud, Robert Georged, Elizabeth Millerb

Accepted 15 December 2009. published online 04 January 2010.

Summary 

Objective

To describe the epidemiology of invasive pneumococcal disease (IPD) in England & Wales in the pre-conjugate vaccine era.

Methods

We analysed reports of culture-confirmed IPD submitted to the national surveillance system between July 1996 and June 2006.

Results

The incidence of IPD was 10 per 100,000 overall, and increased over time. The typical pattern of IPD by age was observed, with the highest incidence in young children and older adults. There was little change in IPD incidence in the elderly, despite the widespread use of 23-valent pneumococcal polysaccharide vaccines since 2003. The distribution of serotypes changed over time; notably the proportion of cases caused by serotype 14 decreased, and the proportion due to serotype 1 increased. The incidence of meningitis was 0.6 per 100,000 overall, and as a proportion of all IPD cases was most common in children under 1 year of age (30%). Particular serotypes were significantly associated with a presentation of meningitis, after controlling for age and year, and the case:carrier ratio varied markedly by serotype.

Conclusions

This paper provides a baseline for evaluating the impact of 7-valent pneumococcal conjugate vaccines, introduced in September 2006. Ongoing high-quality laboratory-based surveillance of IPD in all age groups is essential.

a Department of Social Medicine, University of Bristol, Canynge Hall, Whatley Road, Bristol BS8 2PS, UK

b Immunisation Department, Health Protection Agency Centre for Infections, Colindale, London, UK

c Statistics, Modelling and Economics Department, Health Protection Agency Centre for Infections, Colindale, London, UK

d Respiratory and Systemic Infection Laboratory, Health Protection Agency Centre for Infections, Colindale, London, UK

Corresponding Author InformationCorresponding author. Tel.: +44 117 928 7220.

PII: S0163-4453(09)00392-2

doi:10.1016/j.jinf.2009.12.008


View previous. 2 of 12 View next.